- This event has passed.
2019–2020 HPUS Updates
2019–2020 HPUS Updates: Essential Information Companies Need to Know
FDA’s revised Draft Guidance makes the Homeopathic Pharmacopeia a central focus of the Agency’s definition of what is and what is not homeopathic. Thus, it is more important then ever for your company to be in-the-know regarding changes and updates in the HPUS.
This webinar will review additions and changes to monographs in the HPUS, including updates to quality control tests, revised attenuation levels, and modifications based on input originating outside the Convention. You will hear about new explanatory text regarding the Convention’s distinctions concerning marker compounds in relation to therapeutic activity.
The webinar will also provide you with information about an HPCUS project that is a priority in the coming months. This project will lead to documents focused on five cGMP related issues of particular importance for homeopathic drug products.
All manufacturers and marketers of homeopathic drug products need to be aware of this wide range of information to ensure your products and labeling do not fall into the FDA’s high-risk categories for enforcement action.
Attend this one-hour AAHP Compliance Thru Education webinar for an overview of these changes; attendees can receive (post-webinar) four documents listing the monographs affected by these updates.
Whether you manufacture or just market homeopathic drug products, the new information in the HPUS has a bearing on your products’ compliance status. Regulatory and FDA review of homeopathic products over the past year support the critical importance of being current with the updates in the HPUS. These changes and updates may affect your business, your cGMP compliance, your products, and your long-term success in the market!
WHO SHOULD ATTEND
Quality Control and Quality Assurance Mangers
Staff Responsible for Product Formulations
Staff Responsible for Product and Label Review
CEO’s and Senior Management
*AAHP members will receive a $79 rebate for each registration after the webinar has ended.
For four decades, Eric Foxman RPh has been involved with the HPCUS in many capacities, including its Board, and as chair of the Council on Pharmacy. In this latter role, Eric has helped with the review and revision of compendial documents to keep them current with contemporary cGMP expectations.
Many in the industry know Eric Foxman as a member or company representative of the American Association of Homeopathic Pharmacists since 1979. He is in the 10th year of his third term on the Board of Directors. Eric has been a presenter or host of numerous AAHP Compliance Thru Education webinars addressing legal, regulatory, and technical aspects of the manufacture and marketing of homeopathic drug products; this is his eighth annual webinar on HPUS Updates.
Please click here to register for this webinar. You will receive an email confirmation shortly after you complete the registration.
* Each webinar registration is for one computer/phone connection.
* If it is physically possible at your location, more than one participant may view the live webinar with no additional registration fee.
* The registration fee has been purposefully kept low to make it possible for multiple employees of a company to attend at separate locations. AAHP members will receive a rebate for each registration after the webinar has ended.
* Each registration will automatically receive one (1) Certificate of participation issued in the name of the registered participant. If you would like additional certificates of participation, please send an email to email@example.com to indicate how many additional certificates you wish to purchase at $39 each; you will be contacted after the event for the names to be printed on the additional certificates and to arrange for payment through PayPal.
For more information regarding the webinar, contact Eric Foxman by phone (1-503-659-2715) or by email: firstname.lastname@example.org.